Skip to content

Palladyne AI Corp. PDYN Warrant Liabilities Reclassified To Equity Upon Exercise

Warrant Liabilities Reclassified To Equity Upon Exercise at other companies

Opus Genetics logo
Opus GeneticsIRD
$263K
Opus Genetics logo
Opus GeneticsIRD
$263K
IonQ logo
IonQIONQ
$7.14M-34.8%
HTF
Heartflow, Inc. Common StockHTFL
$16.18M
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
$0-100%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$2.79M

Other financials

Income statement

See full
Revenue$3.5M+107%
Gross profit$1.1M-21.5%
Operating income-$11.9M-72.0%
Net income-$12.6M-155%
EPS (diluted)-$0.28-151%

Balance sheet

See full
Cash & equivalents$17.9M+77.5%
Total debt$10.5M-1.7%
Total equity$69.9M+147%
Total assets$92.6M+46.2%

Cash flow

See full
Operating cash flow-$10.2M-36.2%
CapEx$27.0K-71.0%
Free cash flow-$10.3M-34.9%

Valuation

See full
Market cap$287.24M-10.9%
Enterprise value$279.92M
P/S40.6×

Profitability

See full
Gross margin32%-35.7pp
Operating margin-528.6%+139pp
Net margin-953.5%+449pp
FCF margin-438.3%+73.6pp

Returns & leverage

See full
Return on equity-110.1%-2.5pp
Debt / equity0.2×-0.2×
Current ratio7.8×-8.2×

Where this comes from

Reported directly by Palladyne AI Corp. in its filing.

Tagged under the XBRL concept pdyn:WarrantLiabilitiesReclassifiedToEquityUponExercise.

The official record: Palladyne AI Corp.’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palladyne AI Corp.'s warrant liabilities reclassified to equity upon exercise.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Palladyne AI Corp.'s warrant liabilities reclassified to equity upon exercise?
Palladyne AI Corp. (PDYN) reported warrant liabilities reclassified to equity upon exercise of $2.72M in Q4 2025.
What does warrant liabilities reclassified to equity upon exercise mean?
This metric represents the non-cash accounting adjustment made when outstanding warrants are exercised and converted into common stock. It reflects the transfer of the fair value of these derivative liabilities from the balance sheet into shareholders' equity. This movement highlights the transition of potential dilution into permanent capital and the reduction of volatility associated with warrant liability revaluations.